Inhibition of hepatic gluconeogenesis and lipogenesis by benzoic acid, p-tert.-butylbenzoic acid, and a structurally related hypolipidemic agent SC-33459-Reference-Cited by-同舟云学术

Inhibition of hepatic gluconeogenesis and lipogenesis by benzoic acid, p-tert.-butylbenzoic acid, and a structurally related hypolipidemic agent SC-33459

Published:1982-03 Issue:1 Volume:214 Page:124-133
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

McCune Sylvia A.,Durant Pamela J.,Flanders Lloyd E.,Harris Robert A.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference35 articles.

1. Regulation of fatty acid synthesis at the acetyl-CoA carboxylation step

2. Fatty acid biosynthesis in Erlich cells. The mechanism of short term control by exogenous free fatty acids.

3. Inhibition of Rat-Liver Acetyl-Coenzyme-A Carboxylase by Palmitoyl-Coenzyme A. Formation of Equimolar Enzyme-Inhibitor Complex

4. Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia;Journal of Inherited Metabolic Disease;2022-11-03

2. Towards the mechanism of spermatotoxicity of p-tert-butyl-alpha-methylhydrocinnamic aldehyde: inhibition of late stage ex-vivo spermatogenesis in rat seminiferous tubule cultures by para-tert-butyl- benzoic acid;Archives of Toxicology;2022-09-29

3. Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia;Science Translational Medicine;2021-09-15

4. p-Alkyl-Benzoyl-CoA Conjugates as Relevant Metabolites of Aromatic Aldehydes With Rat Testicular Toxicity—Studies Leading to the Design of a Safer New Fragrance Chemical;Toxicological Sciences;2017-08-30

5. The Impact of Fatty Acid Oxidation on Energy Utilization: Targets and Therapy;Current Pharmaceutical Design;2002-06-01